Technetium-99m Tricarbonyl Labeled a Broad-spectrum Quinolone as a Specific Imaging Agent in Infection Diseases

AuthorSeyed Javad Khoramrouzen
AuthorMostafa Erfanien
AuthorMitra Athari Allafen
Issued Date2017-04-30en
AbstractNuclear medicine imaging has been used to localize infection sites, and efforts have been continued to develop modified infection specific radiopharmaceuticals. In this study gemifloxacin as a broad-spectrum quinolone has been labeled with [99mTc (CO)3 (H2O)3]+ core in order to evaluate its feasibility as an infection imaging agent for in-vivo use. The stability of radioconjugate was checked in human serum at 37 °C and biodistribution was studied in mice. Labeling yield of > 95% was obtained corresponding to a specific activity of 0.14 GBq/μmol. The radioconjugate showed good stability in human serum. Our main achievement was the high accumulation in the infected muscle in mice (T/NT = 2.93 ± 0.3 at 1 h post injection), which may diagnostically be beneficial for differentiate sites of infection from sites of inflammation.en
DOIhttps://doi.org/10.22037/ijpr.2017.2037en
KeywordInfectionen
Keyword<sup>99m</sup>Tc-carbonylen
KeywordGemifloxacinen
KeywordQuinoloneen
KeywordImagingen
PublisherBrieflandsen
TitleTechnetium-99m Tricarbonyl Labeled a Broad-spectrum Quinolone as a Specific Imaging Agent in Infection Diseasesen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-16-611.pdf
Size:
426.1 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF